Clinical Proof of Concept (POC) of Glucokinase Activator HMS5552 Achieved in Chinese T2DM Patients: HbA1c Reduction of 1.22% with 100% Response Rate and Improved β-cell Function

2016 ADA Poster
Hua Medicine
Jun 10, 2016

Online link unavailable, presentationavailable upon request. (

Focus Us
Copyright © 2020  Hua Medicine (Shanghai) Co., Ltd. 沪ICP备14036654号    beiantubiao.png 沪公网安备 31011502013809号